KeratoConus Data Acquisition With Topography and Aberrometry
KC-DATA
Data Collection Study in Keratoconus, Utilizing Topography and Wavefront Aberrometry
1 other identifier
interventional
52
2 countries
2
Brief Summary
This observational study aims to collect real-world wavefront aberrometry and corneal/scleral topography data from individuals with keratoconus and other corneal ectatic disorders. This data will be used to develop and refine a methodology for designing custom-fitted scleral contact lenses with embedded active light management technology. The study will focus on characterizing the optical imperfections (aberrations) and corneal/scleral shape variations in this population to optimize lens design for improved vision and comfort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2025
CompletedFirst Posted
Study publicly available on registry
March 5, 2025
CompletedStudy Start
First participant enrolled
June 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2025
CompletedJanuary 9, 2026
January 1, 2026
5 months
March 4, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Ocular Topography
Mapping of the ocular surface
during the Eyescan procedure
Wavefront aberrometry
Quantification of the wavefront aberrations
during the Eyescan procedure
Secondary Outcomes (8)
Ocular Topography
during the Eyescan procedure
Ocular Topography
during the Eyescan procedure
Ocular Topography
during the Eyescan procedure
Wavefront aberrometry
during the Eyescan procedure
Anterior chamber depth
during the Eyescan procedure
- +3 more secondary outcomes
Study Arms (1)
Keratoconus and corneal ectasia
OTHERwavefront aberrometry and topography measurement through Pentacam AXL Wave device
Interventions
Eyescan with Pentacam AXL Wave
Eligibility Criteria
You may qualify if:
- Age ≥ 18y
- Provide written Informed Consent
- Diagnosed with keratoconus and/or any other type of ectatic corneal disorder
- Cornea considered to be clinically stable at the discretion of the investigator (e.g. no recent cross linking performed, no current corneal sutures, no corneal sutures recently removed).
- Willing to remove current contact lenses for a minimum of 48 hours prior to performing the pentacam AXL Wave scan, if applicable.
You may not qualify if:
- Known active disease-related ocular surface problem (i.e. microbial keratitis)
- History of ocular pathologies that might lead to incomplete/incorrect eye surface scan AND wavefront aberrometry, at the discretion of the investigator
- Use of fluorescein in the eye, within 12 hours prior to the pentacam AXL Wave scan is performed
- Contact lens refitting within one month prior to the pentacam AXL Wave scan, as this can significantly impact the corneal or scleral surface.
- Currently wearing hybrid contact lenses
- Having worn contact lenses within 48 hours prior to performing the pentacam AXL Wave scan. Note: this criteria might not be applicable yet at the time of signing ICF, but needs to be confirmed prior to performing the Pentacam AXL Wave Scan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Azalea Visionlead
Study Sites (2)
University Hospital Antwerp (UZA)
Edegem, 2650, Belgium
Visser Contactlenzen Brunssum
Brunssum, 6443, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Koppen, Prof. Dr.
University Hospital, Antwerp
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2025
First Posted
March 5, 2025
Study Start
June 16, 2025
Primary Completion
November 20, 2025
Study Completion
November 20, 2025
Last Updated
January 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
This study will be registered in a public trial register (clinicaltrials.gov) prior to inclusion of the first subject. The content - including the participating Principal Investigators and Clinical Study Sites - will be updated throughout the conduct of the study. Results information from this study will be submitted to the public trial register.